Axogen Showcases Nerve Repair Vision at Goldman Sachs
Axogen, Inc. (NASDAQ:AXGN) is among the best growth stocks to invest in for the next 5 years. On June 11, 2025, Axogen, Inc.
Axogen Inc. (AXGN)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Soleus Capital Guy Levy | 1,446,117 | $26,753,165 | -52% | 1.93% |
| 2. | Driehaus Capital Richard Driehaus | 1,172,029 | $21,682,537 | +23% | 0.21% |
| 3. | DAFNA Capital Management Nathan Fischel | 680,782 | $12,594,467 | -20% | 3.57% |
| 4. | Balyasny Asset Management Dmitry Balyasny | 680,190 | $12,583,515 | +127% | 0.02% |
| 5. | Marshall Wace LLP Paul Marshall And Ian Wace | 668,255 | $12,362,725 | +630% | 0.02% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $10.50 | 2,525 | $26,512.50 | 25,082 | 2024-08-08 | Filing | |
| $6.22 | 10,000 | $62,240.00 | 80,342 | 2023-09-06 | Filing | |
| $6.56 | 10,000 | $65,600.00 | 10,000 | 2023-08-23 | Filing | |
| $6.11 | 10,000 | $61,100.00 | 68,259 | 2023-08-16 | Filing | |
| $14.10 | 14,170 | $199,797.00 | 15,535 | 2019-08-12 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $10.61 | 4,073 | $43,214.53 | 6,580 | 2025-06-09 | Filing | |
| $10.61 | 4,073 | $43,214.53 | 36,743 | 2025-06-09 | Filing | |
| $10.61 | 4,073 | $43,214.53 | 93,826 | 2025-06-09 | Filing | |
| $10.61 | 4,073 | $43,214.53 | 24,484 | 2025-06-09 | Filing | |
| $10.61 | 4,073 | $43,214.53 | 86,743 | 2025-06-09 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 4,474,215 | $82,772,978 | 9.45% | |
| 2. | 3,550,855 | $65,690,821 | 0% | |
| 3. | 2,601,222 | $48,122,609 | 0% | |
| 4. | 2,538,607 | $46,964,230 | 0% | |
| 5. | 1,591,103 | $29,435,406 | 0.48% |
News See All
15 Best Growth Stocks to Invest in for the Next 5 Years
Before making any decision, whether big or small, we instinctively weigh its long-term impact, and this is particularly true in the case of stocks.
AxoGen, Inc. (NASDAQ:AXGN) Q1 2025 Earnings Call Transcript
Operator: Good morning, everyone.
AxoGen, Inc. (NASDAQ:AXGN) Q4 2024 Earnings Call Transcript
Operator: Good morning everyone.
AxoGen, Inc. (NASDAQ:AXGN) Q3 2024 Earnings Call Transcript
Operator: Good morning, everyone. Joining me on today's call is Michael Dale, Axogen's Chief Executive Officer and Director; and Nir Naor, Chief Financial Officer.
AxoGen, Inc. (NASDAQ:AXGN) Q2 2024 Earnings Call Transcript
Operator: Greetings, and welcome to the AxoGen, Inc. Reports 2024 Second Quarter Financial Results Call. At this time all participants are in a listen-only mode.
AxoGen, Inc. (NASDAQ:AXGN) Q1 2024 Earnings Call Transcript
Operator: Greetings, and welcome to the AxoGen, Inc. 2024 First Quarter Financial Results Conference Call. [Operator Instructions] As a reminder, this conference call is being recorded.
AxoGen, Inc. (NASDAQ:AXGN) Q4 2023 Earnings Call Transcript
AxoGen, Inc. beats earnings expectations. Reported EPS is $-0.06, expectations were $-0.09.
AxoGen, Inc. (NASDAQ:AXGN) Q3 2023 Earnings Call Transcript
Operator: Greetings. Welcome to the AxoGen Reports Third Quarter 2023 Financial Results. At this time, all participants are in a listen-only mode.
AxoGen, Inc. (NASDAQ:AXGN) Q2 2023 Earnings Call Transcript
Operator: Greetings. Welcome to the AxoGen, Inc. Reports Second Quarter 2023 Financial Results Conference Call. At this time, all participants are in a listen-only mode.
Billionaire Hedge Funds
